CoChat

Macrophage Deletion of SOCS1 Increases Sensitivity to LPS and Palmitic Acid and Results in Systemic Inflammation and Hepatic Insulin Resistance

Open access

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Macrophage secretion of proinflammatory cytokines contributes to the pathogenesis of obesity-related insulin resistance. An important regulator of inflammation is the suppressor of cytokine signaling-1 (SOCS1), which inhibits the JAK-STAT and toll-like receptor-4 (TLR4) pathways. Despite the reported role of SOCS1 in inhibiting insulin signaling, it is surprising that a SOCS1 polymorphism that increases SOCS1 promoter activity is associated with enhanced insulin sensitivity despite obesity. In the current study, we investigated the physiological role of myeloid and lymphoid cell SOCS1 in regulating inflammation and insulin sensitivity. RESEARCH DESIGN AND METHODS: We used mice generated by crossing SOCS1 floxed mice with mice expressing Cre recombinase under the control of the LysM-Cre promoter (SOCS1 LysM-Cre). These mice have deletion of SOCS1 in macrophages and lymphocytes. We assessed macrophage inflammation using flow cytometry and serum cytokine levels using Bioplex assays. We then measured insulin sensitivity using glucose tolerance tests and the euglycemic-hyperinsulinemic clamp. Using bone marrow–derived macrophages, we tested the effects of SOCS1 deletion in regulating responses to the TLR4 ligands: lipopolysaccharide (LPS) and palmitic acid. RESULTS: SOCS1 LysM-Cre mice had increased macrophage expression of CD11c, enhanced sensitivity to LPS, and palmitic acid and increased serum concentrations of tumor necrosis factor-α, interleukin-6, and monocyte chemoattractant protein. Increased inflammation was associated with impaired glucose tolerance and hyperinsulinemia as a result of reduced hepatic but not skeletal muscle insulin sensitivity. CONCLUSIONS: The expression of SOCS1 in hematopoietic cells protects mice against systemic inflammation and hepatic insulin resistance potentially by inhibiting LPS and palmitate-induced TLR4 signaling in macrophages.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db11-0259

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1. Deletion of SOCS1 from macrophages results in systemic inflammation. Serum concentrations of TNF-α (A), IL-6 (B), MCP-1 (C), PAI-1 (D), leptin (E), and resistin (F) are shown. ▪, FL/FL control mice; •, SOCS1 LysM-Cre mice. Data are means ± SEM; n = 6.
FIG. 1. Deletion of SOCS1 from macrophages results in systemic inflammation. Serum concentrations of TNF-α (A), IL-6 (B), MCP-1 (C), PAI-1 (D), leptin (E), and resistin (F) are shown. ▪, FL/FL control mice; •, SOCS1 LysM-Cre mice. Data are means ± SEM; n = 6.CC BY-NC-ND · PubMed Central
FIG. 2. Macrophages from SOCS1 LysM-Cre mice are constitutively activated and inflamed. Peritoneal cells were isolated and stained with antibodies against F4/80, CD11b, CD11c, or isotype controls and analyzed by flow cytometry. A: Number of F4/80+CD11b+ cells in wild-type and SOCS1 LysM-Cre mice indicated as percentage of viable peritoneal cell population. B: Cells were gated for F4/80+CD11b+ cells and examined for expression of CD11c. Shown is the percentage of CD11c-positive or -negative cells within the total F4/80+CD11b+ population. A and B: Top panels are representative plots; bottom panels are means ± SEM, n = 8 per group. White bars, FL/FL control mice; black bars, SOCS1 LysM-Cre mice. Representative plots of the intracellular cytokine staining to detect secretion of IL-6 (C) and TNF-α (D) in peritoneal macrophages are shown. For each, cells were gated on the CD11b+ population, and data represented in the graph are combined from two experiments and expressed as mean ± SEM; n = 6 per group. E: Quantitation of cytokine secretion by CD11b+ peritoneal macrophages from littermate control and SOCS1 LysM-Cre mice. Secretion of IL-6, TNF, and MCP-1 by CD11b+ peritoneal macrophages was measured by cytokine bead array. F: Adipose tissue expression of Emr1, Cd68, Tnfa, Il6, and Il1b in SOCS1 LysM-Cre and control mice. Data are shown as mean ± SEM; n = 8 per group. White bars, FL/FL control mice; black bars, SOCS1 LysM-Cre mice. For all experiments, *P < 0.05, **P < 0.01, and ***P < 0.001 relative to control. (A high-quality color representation of this figure is available in the online issue.)
FIG. 2. Macrophages from SOCS1 LysM-Cre mice are constitutively activated and inflamed. Peritoneal cells were isolated and stained with antibodies against F4/80, CD11b, CD11c, or isotype controls and analyzed by flow cytometry. A: Number of F4/80+CD11b+ cells in wild-type and SOCS1 LysM-Cre mice indicated as percentage of viable peritoneal cell population. B: Cells were gated for F4/80+CD11b+ cells and examined for expression of CD11c. Shown is the percentage of CD11c-positive or -negative cells within the total F4/80+CD11b+ population. A and B: Top panels are representative plots; bottom panels are means ± SEM, n = 8 per group. White bars, FL/FL control mice; black bars, SOCS1 LysM-Cre mice. Representative plots of the intracellular cytokine staining to detect secretion of IL-6 (C) and TNF-α (D) in peritoneal macrophages are shown. For each, cells were gated on the CD11b+ population, and data represented in the graph are combined from two experiments and expressed as mean ± SEM; n = 6 per group. E: Quantitation of cytokine secretion by CD11b+ peritoneal macrophages from littermate control and SOCS1 LysM-Cre mice. Secretion of IL-6, TNF, and MCP-1 by CD11b+ peritoneal macrophages was measured by cytokine bead array. F: Adipose tissue expression of Emr1, Cd68, Tnfa, Il6, and Il1b in SOCS1 LysM-Cre and control mice. Data are shown as mean ± SEM; n = 8 per group. White bars, FL/FL control mice; black bars, SOCS1 LysM-Cre mice. For all experiments, *P < 0.05, **P < 0.01, and ***P < 0.001 relative to control. (A high-quality color representation of this figure is available in the online issue.)CC BY-NC-ND · PubMed Central
FIG. 3. SOCS1 LysM-Cre mice have increased sensitivity to LPS and palmitate, Tnfa (A and D), Il6 (B and E), and Il1b (C and F) measured by RT-quantitative PCR after stimulation of bone marrow–derived macrophages from wild-type and SOCS1 LysM-Cre mice with increasing concentrations of LPS and palmitate, respectively. Data are means ± SEM; n = 3 per group. White bars, FL/FL control mice; black bars, SOCS1 LysM-Cre mice. *P < 0.05 genotype effect relative to control.
FIG. 3. SOCS1 LysM-Cre mice have increased sensitivity to LPS and palmitate, Tnfa (A and D), Il6 (B and E), and Il1b (C and F) measured by RT-quantitative PCR after stimulation of bone marrow–derived macrophages from wild-type and SOCS1 LysM-Cre mice with increasing concentrations of LPS and palmitate, respectively. Data are means ± SEM; n = 3 per group. White bars, FL/FL control mice; black bars, SOCS1 LysM-Cre mice. *P < 0.05 genotype effect relative to control.CC BY-NC-ND · PubMed Central
FIG. 4. Glucose intolerance in SOCS1 LysM-Cre mice. A: Hyperinsulinemia and glucose intolerance (B and C) as assessed by increased area under the curve during GTT. White bars and open white circles, FL/FL control mice; black bars and black squares, SOCS1 LysM-Cre mice. Data are means ± SEM; n = 10–12. *P < 0.05 genotype effect relative to control; ***P < 0.001 relative to control.
FIG. 4. Glucose intolerance in SOCS1 LysM-Cre mice. A: Hyperinsulinemia and glucose intolerance (B and C) as assessed by increased area under the curve during GTT. White bars and open white circles, FL/FL control mice; black bars and black squares, SOCS1 LysM-Cre mice. Data are means ± SEM; n = 10–12. *P < 0.05 genotype effect relative to control; ***P < 0.001 relative to control.CC BY-NC-ND · PubMed Central
FIG. 5. Hepatic insulin resistance in SOCS1 LysM-Cre mice. Glucose infusion rate (GIR) (A) and glucose disposal rate (GDR) (B). HGP (C) and HGP% (D) suppression during euglycemic clamp are shown. White bars, FL/FL control mice; black bars, SOCS1 LysM-Cre mice. Data are means ± SEM; n = 10–12. ***P < 0.001 relative to control.
FIG. 5. Hepatic insulin resistance in SOCS1 LysM-Cre mice. Glucose infusion rate (GIR) (A) and glucose disposal rate (GDR) (B). HGP (C) and HGP% (D) suppression during euglycemic clamp are shown. White bars, FL/FL control mice; black bars, SOCS1 LysM-Cre mice. Data are means ± SEM; n = 10–12. ***P < 0.001 relative to control.CC BY-NC-ND · PubMed Central
FIG. 6. Impaired hepatic insulin signaling in SOCS1 LysM-Cre mice is associated with increased liver inflammation. Reduced IRS-1 tyrosine phosphorylation, IRS-1–associated p85-subunit of PI-3 kinase, and Akt phosphorylation in liver of SOCS1 LysM-Cre mice (A) are shown. B: Increased expression of PEPCK and G6Pase in clamped liver as measured via RT-quantitative PCR. C: Increased inflammatory signaling in liver of SOCS1 LysM-Cre mice. Data are means ± SEM; n = 12 mice per group. White bars, FL/FL control mice; black bars, SOCS1 LysM-Cre mice. *P < 0.05 and **P < 0.01 relative to control. KO, SOCS1 LysM-Cre.
FIG. 6. Impaired hepatic insulin signaling in SOCS1 LysM-Cre mice is associated with increased liver inflammation. Reduced IRS-1 tyrosine phosphorylation, IRS-1–associated p85-subunit of PI-3 kinase, and Akt phosphorylation in liver of SOCS1 LysM-Cre mice (A) are shown. B: Increased expression of PEPCK and G6Pase in clamped liver as measured via RT-quantitative PCR. C: Increased inflammatory signaling in liver of SOCS1 LysM-Cre mice. Data are means ± SEM; n = 12 mice per group. White bars, FL/FL control mice; black bars, SOCS1 LysM-Cre mice. *P < 0.05 and **P < 0.01 relative to control. KO, SOCS1 LysM-Cre.CC BY-NC-ND · PubMed Central
FIG. 7. Increased liver inflammatory cell infiltration in SOCS1 LysM-Cre mice. Liver sections from SOCS1 LysM-Cre (A and C–G) and FL/FL controls (B and H–L) stained as follows: hematoxylin-eosin (A and B), CD11b (C and H), CD11c (D and I), CD4 (E and J), CD8 (F and K), and B220 (G and L). (A high-quality digital representation of this figure is available in the online issue.)
FIG. 7. Increased liver inflammatory cell infiltration in SOCS1 LysM-Cre mice. Liver sections from SOCS1 LysM-Cre (A and C–G) and FL/FL controls (B and H–L) stained as follows: hematoxylin-eosin (A and B), CD11b (C and H), CD11c (D and I), CD4 (E and J), CD8 (F and K), and B220 (G and L). (A high-quality digital representation of this figure is available in the online issue.)CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Cited by

See all 81

Metadata

Authors
Sachithanandan, N., Graham, K. L., Galic, S., Honeyman, J. E., Fynch, S. L., Hewitt, K. A., Steinberg, G. R., & Kay, T. W.
Affiliations
  • The University of Melbourne (AU)
  • St. Vincent's Institute of Medical Research and Department of Medicine, University of Melbourne, Fitzroy, Victoria, Australia
Corresponding author
  • Sachithanandan, Nirupa
  • Steinberg, Gregory R.
Venue
Diabetes
Published
2011-07-18
Volume
60
Issue
8
Pages
2023-2031
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2158083455
Cited by
81
References
46
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 4 · 2021: 4 · 2020: 4 · 2019: 7 · 2018: 5 · 2017: 5 · 2016: 5 · 2015: 6 · 2014: 5 · 2013: 13 · 2012: 10
FWCI
7.23
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
Funders
Canadian Institutes of Health Research
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords
SOCS1, macrophages, systemic inflammation, hepatic insulin resistance, lipopolysaccharide, palmitic acid, TLR4 signaling, JAK/STAT signaling, obesity, glucose tolerance, TNF-α, interleukin-6, monocyte chemoattractant protein, hematopoietic cells
MeSH terms
Suppressor of Cytokine Signaling 1 Protein, Animals, Inflammation, Insulin, Insulin Resistance, Lipopolysaccharides, Liver, Macrophages, Male, Mice, Knockout, Palmitic Acid, Suppressor of Cytokine Signaling Proteins, Toll-Like Receptors, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.